7year Old Boy Battles Cancer With Karate, Swimming, Snorkeling

Enduring chemotherapy for acute lymphoblastic leukemia, 7year old Joel Waters has still managed to achieve an orange belt in karate.

Enduring chemotherapy for acute lymphoblastic leukemia, 7year old Joel Waters has still managed to achieve an orange belt in karate. This Melbourne boy was diagnosed with leukemia in 2007. However the prognosis for his recovery has been positive so far. He is also preparing to go to second grade in school from this week.

The treatment was intensive in the early stages and took its toll on young Joel. Due to the side-effects of chemotherapy Joel had hunger cravings which lead to 4kg weight gain in about 3weeks. When he was 3years old, he lost the ability to walk due to effects of the drug on nerve endings.

Acute Lymphoblastic Leukemia - Incidence Causes Symptoms Diagnosis Treatment Prognosis
Acute lymphoblastic leukemia (ALL) is the cancer of white blood cells characterized by excess lymphoblasts. It is the most common of all childhood cancers and can be fatal in weeks if left untreated.

2 years ago, Joel began karate lessons, swimming and snorkeling. Joel said, "During the treatment, karate lessons made me feel better." Joel's oncologist at Monash Children's Hospital, Dr Pratiti Bandopadhayay says, "90 per cent of children with the seven-year-old's form of cancer will be cured. It was very rewarding seeing Joel preparing to go to school this week."

Source-Medindia

New Treatment Discovered For Acute Lymphoblastic Leukemia
Reserachers have recently discovered a new line of treatment for patients with acute lymphoblastic leukemia

Acute Lymphoblastic Leukemia May Attain a 90% Cure Rate
The progressive improvement in the cure rate since 1962, when only 4% of children with ALL survived, reflects in large part the more effective use of existing drugs.

Acute Lymphoblastic Leukemia Treatment In Children Possible Sans Preventive Cranial Radiation
Childhood acute lymphoblastic leukemia (ALL) can be successfully treated using a carefully personalized chemotherapy regimen without cranial radiation, investigators at St.